Veradermics, Incorporated · NYSE:MANE
Waldman Reid Alexander sold 67,500 Veradermics, Incorporated shares (Form 4)
Traded Aug 17, 2026 · Filed Aug 18, 2026
On Aug 17, 2026, Waldman Reid Alexander (Director, Chief Executive Officer) sold 67,500 Veradermics, Incorporated shares at an average US$107.86 for US$7.28M under a trading plan, leaving 170,824 shares. Filed Aug 18, 2026 (Form 4).
- Sold
- 67,500 shares
- Price
- US$107.86 average (US$106.72 to US$111.28)
- Value
- US$7.28M
- Holding after
- 170,824 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | Option exercise | 3,452 | US$12.19 | 238,324 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 11,527 | US$106.72 | 226,797 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 25,234 | US$107.53 | 201,563 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 27,490 | US$108.45 | 174,073 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 3,000 | US$109.38 | 171,073 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 249 | US$111.28 | 170,824 | Direct |
Source
Related
- Veradermics, Incorporated
- Waldman Reid Alexander
- Veradermics, Incorporated shareholders
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Hollander David · Sep 3, 2026
- Form 4 · Averill Master Fund, Ltd. · Aug 21, 2026
- Schedule 13D/A · Montanova Capital, LLC · Aug 21, 2026
- Form 4 · Durso Timothy August · Aug 18, 2026